Form 4: Omada Health Director Acquires Shares

Omada Health Director Jeryl L. Hilleman acquired 10,882 shares of common stock through restricted stock units.

Summary

• Jeryl L. Hilleman, a Director at Omada Health, Inc., acquired 10,882 shares of common stock on June 16, 2026.
• These shares were acquired through restricted stock units (RSUs).
• The RSUs will vest fully on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of Stockholders, provided the reporting person remains in service.
• Following this transaction, the reporting person beneficially owns 25,220 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard RSU vesting and acquisition by a director, indicating continued engagement but not necessarily a significant new investment or strategic shift.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 10,882 shares indicates continued commitment from a key insider.

Future Outlook

The restricted stock units are set to vest on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of Stockholders, contingent on continued service.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of shares by a director, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance within the digital health sector.

Stakeholder Impact

• Shareholders: The acquisition by a director may be interpreted as a positive signal of confidence in the company's future performance.

Next Steps

• Vesting of restricted stock units on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of Stockholders.

Key Dates

Keywords

Omada Health, Form 4, Insider Trading, Restricted Stock Units, Common Stock, Director, SEC Filing